MIAMI and HAIFA, Israel, June 18, 2026 /PRNewswire/ — Insightec, a global healthcare company dedicated to using MR-guided focused ultrasound (MRgFUS) to transform patient care, today announced the publication of pivotal Parkinson’s disease (PD) clinical trial results in The Lancet Neurology. Using Insightec’s Exablate® Neuro system, this prospective, multicenter study evaluated staged bilateral MRgFUS treatment for Parkinson’s disease and demonstrates that the incisionless procedure produces substantial and durable improvements in disabling motor symptoms, with benefits appearing within one month and sustained through 12 months.  

Read more here.